91桃色

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open 91桃色

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Prevalence of drug-drug interactions in an Ethiopian teaching hospital

International Summit on Clinical Pharmacy & Dispensing

Fisseha Shiferie

Accepted Abstracts: Clinic Pharmacol Biopharmaceut

DOI:

Abstract
Drug-drug interaction (DDI) refers to the interference of a drug in the action of another drug. Frequency of drug interactions varies with the number of drugs used in combination; from 3 to 5 % in patients receiving few drugs to 20% when 10 to 20 drugs are used. Computer systems have proved helpful in identifying interactions that otherwise are increasingly enormous and difficult to keep track for health professionals. The purpose of the present study was to assess the prevalence of DDIs in an Ethiopian teaching hospital from prescription papers containing two or more drugs. A retrospective study of prescription papers containing two or more drugs from September 2012 to January 2013 was carried out and the analysis of potential drug interactions was done using the online version of Micromedex /Drug-Reax system. 964 prescriptions containing more than two dugs were collected and a total of 580 potential drug interactions were found. The interaction between Ampicillin and Gentamicin, found in (29.48%) prescriptions, was the most prevalent; though with minor severity. During the study period the most prevalent drug interaction with major severity was that between Digoxin and Spironolactone (13.44%). The presence of drug interactions is a permanent risk in hospitals. The utilization of computer programs to identify potentially interacting drug combinations and the pharmacist participation in pharmacotherapy decision making are some ways of reducing this risk.
Biography
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top